vs
SILGAN HOLDINGS INC（SLGN）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
Solventum的季度营收约是SILGAN HOLDINGS INC的1.4倍（$2.0B vs $1.5B），Solventum净利率更高（3.2% vs 1.2%，领先1.9%），SILGAN HOLDINGS INC同比增速更快（4.1% vs -3.7%），SILGAN HOLDINGS INC自由现金流更多（$1.2B vs $32.0M），过去两年SILGAN HOLDINGS INC的营收复合增速更高（5.6% vs -0.4%）
西尔根控股是一家总部位于美国康涅狄格州的消费品包装制造企业，1987年由原大陆制罐公司的两名高管菲尔·西尔弗与格雷格·霍里根共同创立，公司名称正是取自两位创始人的名字组合，目前在全球包装供应链中占据重要市场地位，为众多快消品牌提供各类包装解决方案。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
SLGN vs SOLV — 直观对比
营收规模更大
SOLV
是对方的1.4倍
$1.5B
营收增速更快
SLGN
高出7.8%
-3.7%
净利率更高
SOLV
高出1.9%
1.2%
自由现金流更多
SLGN
多$1.2B
$32.0M
两年增速更快
SLGN
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $2.0B |
| 净利润 | $18.2M | $63.0M |
| 毛利率 | 17.2% | 51.4% |
| 营业利润率 | 3.6% | 6.3% |
| 净利率 | 1.2% | 3.2% |
| 营收同比 | 4.1% | -3.7% |
| 净利润同比 | -59.6% | 103.2% |
| 每股收益（稀释后） | $0.18 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SLGNSOLV
| Q4 25 | $1.5B | $2.0B | ||
| Q3 25 | $2.0B | $2.1B | ||
| Q2 25 | $1.5B | $2.2B | ||
| Q1 25 | $1.5B | $2.1B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.7B | $2.1B | ||
| Q2 24 | $1.4B | $2.1B | ||
| Q1 24 | $1.3B | $2.0B |
净利润SLGNSOLV
| Q4 25 | $18.2M | $63.0M | ||
| Q3 25 | $113.3M | $1.3B | ||
| Q2 25 | $88.9M | $90.0M | ||
| Q1 25 | $68.0M | $137.0M | ||
| Q4 24 | $45.1M | $31.0M | ||
| Q3 24 | $100.1M | $122.0M | ||
| Q2 24 | $76.1M | $89.0M | ||
| Q1 24 | $55.2M | $237.0M |
毛利率SLGNSOLV
| Q4 25 | 17.2% | 51.4% | ||
| Q3 25 | 16.3% | 54.2% | ||
| Q2 25 | 19.4% | 54.4% | ||
| Q1 25 | 18.4% | 53.8% | ||
| Q4 24 | 16.9% | 53.9% | ||
| Q3 24 | 16.8% | 56.0% | ||
| Q2 24 | 18.5% | 54.6% | ||
| Q1 24 | 17.0% | 58.1% |
营业利润率SLGNSOLV
| Q4 25 | 3.6% | 6.3% | ||
| Q3 25 | 7.4% | 80.6% | ||
| Q2 25 | 7.7% | 9.9% | ||
| Q1 25 | 6.0% | 7.3% | ||
| Q4 24 | 3.4% | 6.6% | ||
| Q3 24 | 7.2% | 13.2% | ||
| Q2 24 | 7.3% | 11.7% | ||
| Q1 24 | 5.5% | 18.9% |
净利率SLGNSOLV
| Q4 25 | 1.2% | 3.2% | ||
| Q3 25 | 5.6% | 60.4% | ||
| Q2 25 | 5.8% | 4.2% | ||
| Q1 25 | 4.6% | 6.6% | ||
| Q4 24 | 3.2% | 1.5% | ||
| Q3 24 | 5.7% | 5.9% | ||
| Q2 24 | 5.5% | 4.3% | ||
| Q1 24 | 4.2% | 11.8% |
每股收益（稀释后）SLGNSOLV
| Q4 25 | $0.18 | $0.37 | ||
| Q3 25 | $1.06 | $7.22 | ||
| Q2 25 | $0.83 | $0.51 | ||
| Q1 25 | $0.63 | $0.78 | ||
| Q4 24 | $0.42 | $0.18 | ||
| Q3 24 | $0.93 | $0.70 | ||
| Q2 24 | $0.71 | $0.51 | ||
| Q1 24 | $0.52 | $1.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $878.0M |
| 总债务越低越好 | — | $5.0B |
| 股东权益账面价值 | $2.3B | $5.0B |
| 总资产 | $9.4B | $14.3B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资SLGNSOLV
| Q4 25 | $1.1B | $878.0M | ||
| Q3 25 | $389.2M | $1.6B | ||
| Q2 25 | $317.5M | $492.0M | ||
| Q1 25 | $353.0M | $534.0M | ||
| Q4 24 | $822.9M | $762.0M | ||
| Q3 24 | $368.5M | $772.0M | ||
| Q2 24 | $302.8M | $897.0M | ||
| Q1 24 | $308.6M | $996.0M |
总债务SLGNSOLV
| Q4 25 | — | $5.0B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $7.9B | ||
| Q4 24 | — | $8.0B | ||
| Q3 24 | — | $8.1B | ||
| Q2 24 | — | $8.3B | ||
| Q1 24 | — | $8.3B |
股东权益SLGNSOLV
| Q4 25 | $2.3B | $5.0B | ||
| Q3 25 | $2.3B | $5.0B | ||
| Q2 25 | $2.2B | $3.6B | ||
| Q1 25 | $2.1B | $3.3B | ||
| Q4 24 | $2.0B | $3.0B | ||
| Q3 24 | $2.1B | $3.2B | ||
| Q2 24 | $1.9B | $2.9B | ||
| Q1 24 | $1.9B | $3.9B |
总资产SLGNSOLV
| Q4 25 | $9.4B | $14.3B | ||
| Q3 25 | $9.5B | $14.0B | ||
| Q2 25 | $9.4B | $15.1B | ||
| Q1 25 | $8.8B | $14.5B | ||
| Q4 24 | $8.6B | $14.5B | ||
| Q3 24 | $7.7B | $14.7B | ||
| Q2 24 | $7.7B | $14.6B | ||
| Q1 24 | $7.6B | $14.7B |
负债/权益比SLGNSOLV
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 2.14× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | 2.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $95.0M |
| 自由现金流经营现金流 - 资本支出 | $1.2B | $32.0M |
| 自由现金流率自由现金流/营收 | 83.2% | 1.6% |
| 资本支出强度资本支出/营收 | 4.9% | 3.2% |
| 现金转化率经营现金流/净利润 | 71.07× | 1.51× |
| 过去12个月自由现金流最近4个季度 | $422.7M | $-10.0M |
8季度趋势，按日历期对齐
经营现金流SLGNSOLV
| Q4 25 | $1.3B | $95.0M | ||
| Q3 25 | $340.9M | $76.0M | ||
| Q2 25 | $-221.4M | $169.0M | ||
| Q1 25 | $-683.4M | $29.0M | ||
| Q4 24 | $935.8M | $219.0M | ||
| Q3 24 | $313.0M | $169.0M | ||
| Q2 24 | $20.9M | $355.0M | ||
| Q1 24 | $-547.8M | $442.0M |
自由现金流SLGNSOLV
| Q4 25 | $1.2B | $32.0M | ||
| Q3 25 | $260.8M | $-21.0M | ||
| Q2 25 | $-294.2M | $59.0M | ||
| Q1 25 | $-766.3M | $-80.0M | ||
| Q4 24 | $865.0M | $92.0M | ||
| Q3 24 | $252.4M | $76.0M | ||
| Q2 24 | $-35.3M | $297.0M | ||
| Q1 24 | $-623.1M | $340.0M |
自由现金流率SLGNSOLV
| Q4 25 | 83.2% | 1.6% | ||
| Q3 25 | 13.0% | -1.0% | ||
| Q2 25 | -19.1% | 2.7% | ||
| Q1 25 | -52.2% | -3.9% | ||
| Q4 24 | 61.3% | 4.4% | ||
| Q3 24 | 14.5% | 3.7% | ||
| Q2 24 | -2.6% | 14.3% | ||
| Q1 24 | -47.3% | 16.9% |
资本支出强度SLGNSOLV
| Q4 25 | 4.9% | 3.2% | ||
| Q3 25 | 4.0% | 4.6% | ||
| Q2 25 | 4.7% | 5.1% | ||
| Q1 25 | 5.7% | 5.3% | ||
| Q4 24 | 5.0% | 6.1% | ||
| Q3 24 | 3.5% | 4.5% | ||
| Q2 24 | 4.1% | 2.8% | ||
| Q1 24 | 5.7% | 5.1% |
现金转化率SLGNSOLV
| Q4 25 | 71.07× | 1.51× | ||
| Q3 25 | 3.01× | 0.06× | ||
| Q2 25 | -2.49× | 1.88× | ||
| Q1 25 | -10.06× | 0.21× | ||
| Q4 24 | 20.77× | 7.06× | ||
| Q3 24 | 3.13× | 1.39× | ||
| Q2 24 | 0.27× | 3.99× | ||
| Q1 24 | -9.93× | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SLGN
| Metal Containers | $675.6M | 46% |
| Dispensing And Specialty Closures | $643.6M | 44% |
| Custom Containers | $149.4M | 10% |
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
